Literature DB >> 27604872

A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network.

Ashwin Unnikrishnan1, Yi F Guan2, Yizhou Huang2, Dominik Beck2,3, Julie A I Thoms2, Sofie Peirs4, Kathy Knezevic2, Shiyong Ma2, Inge V de Walle5, Ineke de Jong6, Zara Ali7, Ling Zhong8, Mark J Raftery8, Tom Taghon5, Jonas Larsson6, Karen L MacKenzie7, Pieter Van Vlierberghe4, Jason W H Wong9, John E Pimanda10,11.   

Abstract

Aberrant stem cell-like gene regulatory networks are a feature of leukaemogenesis. The ETS-related gene (ERG), an important regulator of normal haematopoiesis, is also highly expressed in T-ALL and acute myeloid leukaemia (AML). However, the transcriptional regulation of ERG in leukaemic cells remains poorly understood. In order to discover transcriptional regulators of ERG, we employed a quantitative mass spectrometry-based method to identify factors binding the 321 bp ERG +85 stem cell enhancer region in MOLT-4 T-ALL and KG-1 AML cells. Using this approach, we identified a number of known binders of the +85 enhancer in leukaemic cells along with previously unknown binders, including ETV6 and IKZF1. We confirmed that ETV6 and IKZF1 were also bound at the +85 enhancer in both leukaemic cells and in healthy human CD34+ haematopoietic stem and progenitor cells. Knockdown experiments confirmed that ETV6 and IKZF1 are transcriptional regulators not just of ERG, but also of a number of genes regulated by a densely interconnected network of seven transcription factors. At last, we show that ETV6 and IKZF1 expression levels are positively correlated with expression of a number of heptad genes in AML and high expression of all nine genes confers poorer overall prognosis.
© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27604872      PMCID: PMC5159545          DOI: 10.1093/nar/gkw804

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  83 in total

Review 1.  Leukaemia stem cells and the evolution of cancer-stem-cell research.

Authors:  Brian J P Huntly; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

Review 2.  A new transcription factor family associated with human leukemias.

Authors:  N A Speck; S Terryl
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1995       Impact factor: 1.807

3.  Redundant mechanisms to form silent chromatin at pericentromeric regions rely on BEND3 and DNA methylation.

Authors:  Nehmé Saksouk; Teresa K Barth; Celine Ziegler-Birling; Nelly Olova; Agnieszka Nowak; Elodie Rey; Julio Mateos-Langerak; Serge Urbach; Wolf Reik; Maria-Elena Torres-Padilla; Axel Imhof; Jérome Déjardin; Elisabeth Simboeck
Journal:  Mol Cell       Date:  2014-11-06       Impact factor: 17.970

4.  Tip60 is a nuclear hormone receptor coactivator.

Authors:  M E Brady; D M Ozanne; L Gaughan; I Waite; S Cook; D E Neal; C N Robson
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  Frequent Derepression of the Mesenchymal Transcription Factor Gene FOXC1 in Acute Myeloid Leukemia.

Authors:  Tim D D Somerville; Daniel H Wiseman; Gary J Spencer; Xu Huang; James T Lynch; Hui Sun Leong; Emma L Williams; Edmund Cheesman; Tim C P Somervaille
Journal:  Cancer Cell       Date:  2015-09-14       Impact factor: 31.743

6.  Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival.

Authors:  Hanno Hock; Eliza Meade; Sarah Medeiros; Jeffrey W Schindler; Peter J M Valk; Yuko Fujiwara; Stuart H Orkin
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

7.  ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.

Authors:  Klaus H Metzeler; Annika Dufour; Tobias Benthaus; Manuela Hummel; Maria-Cristina Sauerland; Achim Heinecke; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Ulrich Mansmann; Jan Braess; Karsten Spiekermann; Wolfgang Hiddemann; Christian Buske; Stefan K Bohlander
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

8.  Purification of proteins associated with specific genomic Loci.

Authors:  Jérôme Déjardin; Robert E Kingston
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

9.  An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

Authors:  E Clappier; M F Auclerc; J Rapion; M Bakkus; A Caye; A Khemiri; C Giroux; L Hernandez; E Kabongo; S Savola; T Leblanc; K Yakouben; G Plat; V Costa; A Ferster; S Girard; O Fenneteau; J M Cayuela; F Sigaux; N Dastugue; S Suciu; Y Benoit; Y Bertrand; J Soulier; H Cavé
Journal:  Leukemia       Date:  2013-09-25       Impact factor: 11.528

10.  Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation.

Authors:  Kwang Won Jeong; Kyunghwan Kim; Alan Jialun Situ; Tobias S Ulmer; Woojin An; Michael R Stallcup
Journal:  Nat Struct Mol Biol       Date:  2011-11-13       Impact factor: 15.369

View more
  6 in total

1.  GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia.

Authors:  Alexander Y Yang; Robert Albero; Laura Belver; Daniel Herranz; Francesco G Brundu; S Aidan Quinn; Pablo Pérez-Durán; Silvia Álvarez; Francesca Gianni; Marissa Rashkovan; Devya Gurung; Pedro P Rocha; Ramya Raviram; Clara Reglero; Jose R Cortés; Anisha J Cooke; Agnieszka A Wendorff; Valentina Cordó; Jules P Meijerink; Raúl Rabadan; Adolfo A Ferrando
Journal:  Cancer Discov       Date:  2019-09-13       Impact factor: 39.397

2.  Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.

Authors:  Elodie Bal; Rahul Kumar; Mohammad Hadigol; Antony B Holmes; Laura K Hilton; Jui Wan Loh; Kostiantyn Dreval; Jasper C H Wong; Sofija Vlasevska; Clarissa Corinaldesi; Rajesh Kumar Soni; Katia Basso; Ryan D Morin; Hossein Khiabanian; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Nature       Date:  2022-07-06       Impact factor: 69.504

3.  High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.

Authors:  Elena Vendramini; Marco Giordan; Emanuela Giarin; Barbara Michielotto; Grazia Fazio; Gianni Cazzaniga; Andrea Biondi; Daniela Silvestri; Maria Grazia Valsecchi; Martina U Muckenthaler; Andreas E Kulozik; Valter Gattei; Shai Izraeli; Giuseppe Basso; Geertruy Te Kronnie
Journal:  Oncotarget       Date:  2017-06-27

4.  T cell epigenetic remodeling and accelerated epigenetic aging are linked to long-term immune alterations in childhood cancer survivors.

Authors:  Sara Daniel; Vibe Nylander; Lars R Ingerslev; Ling Zhong; Odile Fabre; Briana Clifford; Karen Johnston; Richard J Cohn; Romain Barres; David Simar
Journal:  Clin Epigenetics       Date:  2018-11-06       Impact factor: 6.551

5.  Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity.

Authors:  Yali Ding; Bo Zhang; Feng Yue; Sinisa Dovat; Jonathon L Payne; Chunhua Song; Zheng Ge; Chandrika Gowda; Soumya Iyer; Pavan K Dhanyamraju; Glenn Dorsam; Mark E Reeves; Dhimant Desai; Suming Huang; Kimberly J Payne
Journal:  Leukemia       Date:  2019-05-09       Impact factor: 11.528

6.  Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Jonathon L Payne; Chunhua Song; Yali Ding; Pavan Kumar Dhanyamraju; Yevgeniya Bamme; Joseph W Schramm; Dhimant Desai; Arati Sharma; Chandrika Gowda; Sinisa Dovat
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.